| | |
|---|
| 2019 | Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus
Zayed, Ahmed; Hahn, Thomas; Finkelmeier, Doris; Burger-Kentischer, Anke; Rupp, Steffen; Krämer, Roland; Ulber, Roland | Zeitschriftenaufsatz |
| 2018 | Computationally designed bispecific MD2/CD14 binding peptides show TLR4 agonist activity
Michaeli, Amit; Mezan, Shaul; Kühbacher, Andreas; Finkelmeier, Doris; Elias, Maayan; Zatsepin, Maria; Reed, Steven G.; Duthie, Malcolm S.; Rupp, Steffen; Lerner, Immanuel; Burger-Kentischer, Anke | Zeitschriftenaufsatz |
| 2017 | Central role for dermal fibroblasts in skin model protection against Candida albicans
Kühbacher, A.; Henkel, H.; Stevens, P.; Grumaz, C.; Finkelmeier, D.; Burger-Kentischer, A.; Sohn, K.; Rupp, S. | Zeitschriftenaufsatz |
| 2016 | Computational discovery and experimental confirmation of TLR9 receptor antagonist leads
Zatsepin, Maria; Mattes, Angela; Rupp, Steffen; Finkelmeier, Doris; Basu, Arijit; Burger-Kentischer, Anke; Goldblum, Amriam | Zeitschriftenaufsatz |
| 2016 | Physicochemical and biological characterization of fucoidan from Fucus vesiculosus purified by dye affinity chromatography
Zayed, Ahmed; Muffler, Kai; Hahn, Thomas; Rupp, Steffen; Finkelmeier, Doris; Burger-Kentischer, Anke; Ulber, Roland | Zeitschriftenaufsatz |
| 2013 | An in vitro HSV-1 reactivation model containing quiescently infected PC12 cells
Hogk, I.; Kaufmann, M.; Finkelmeier, D.; Rupp, S.; Burger-Kentischer, A. | Zeitschriftenaufsatz |
| 2012 | Identification and characterisation of novel antifungal compounds against fungal human pathogens
Keller, P.D.; Burger-Kentischer, A.; Finkelmeier, D.; Wiesmuller, K.H.; Lemuth, K.; Hiller, E.; Engelhardt, I.; Muller, C.; Schroppel, K.; Bracher, F.; Rupp, S. | Konferenzbeitrag, Zeitschriftenaufsatz |
| 2011 | High-throughput-screening-based identification and structure-activity relationship characterization defined (S)-2-(1-aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole as a highly antimycotic agent nontoxic to cell lines
Bauer, J.; Kinast, S.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Rayyan, W.A.; Schröppel, K.; Singh, A.; Jung, G.; Wiesmüller, K.-H.; Rupp, S.; Eickhoff, H. | Zeitschriftenaufsatz |
| 2011 | Identification and characterisation of novel antifungal compounds using a screening assay based on host-pathogen interaction models
Keller, P.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Wiesmuller, K.H.; Lemuth, K.; Hiller, E.; Rupp, S. | Abstract |
| 2011 | In vitro 3D Reporter-Hautmodell
Burger-Kentischer, Anke; Finkelmeier, D.; Rupp, Steffen; Kaufmann, M. | Patent |
| 2011 | In vitro- Testsystem für virale Infektionen
Burger-Kentischer, A.; Hogk, I.; Finkelmeier, D.; Walles, H.; Rupp, S.; Kaufmann, M. | Patent |
| 2011 | A new class of antimycotic (S)-2-aminoalkyl benzimidazoles exhibits potent antifungal activity against clinically relevant and against fluconazole resistant strains of Candida spp
Bauer, J.; Kinast, S.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Abu Rayyan, W.; Schroppel, K.; Singh, A.; Spohn, R.; Jung, G.; Wiesmüller, K.-H.; Rupp, S.; Eickhoff, H. | Abstract |
| 2011 | A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives
Burger-Kentischer, A.; Finkelmeier, D.; Keller, P.; Bauer, J.; Eickhoff, H.; Kleymann, G.; Rayyan, W.A.; Singh, A.; Schröppel, K.; Lemuth, K.; Wiesmüller, K.-H.; Rupp, S. | Zeitschriftenaufsatz |
| 2010 | Identification of novel antifungal compounds using a HTS activity-selectivity assay
Keller, P.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Wiesmüller, K.H.; Lemuth, K.; Hiller, E.; Rupp, S. | Abstract |
| 2010 | A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens
Burger-Kentischer, A.; Abele, I.S.; Finkelmeier, D.; Wiesmüller, K.-H.; Rupp, S. | Zeitschriftenaufsatz |
| 2009 | Identification of novel antifungal compounds using a HTS activity-selectivity assay
Keller, P.; Burger-Kentischer, A.; Finkelmeier, D.; Kleymann, G.; Wiesmüller, K.H.; Lemuth, K.; Hiller, E.; Rupp, S. | Abstract |
| 2007 | Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe
Rupp, S.; Burger-Kentischer, A.; Finkelmeier, D.; Wiesmüller, K.-H.; Bauer, J.; Kleymann, G.; Eickhoff, H. | Patent |
| 2006 | Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF)
Burger-Kentischer, A.; Göbel, H.; Kleemann, R.; Zernecke, A.; Bucala, R.; Leng, L.; Finkelmeier, D.; Geiger, G.; Schaefer, H.E.; Schober, A.; Weber, C.; Brunner, H.; Rütten, H.; Ihling, C.; Bernhagen, J. | Zeitschriftenaufsatz |
| 2006 | Zellulärer Pyrogentest
Brunner, H.; Finkelmeier, D.; Geiger, G.; Burger-Kentischer, A. | Patent |
| 2005 | Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif
Burger-Kentischer, A.; Finkelmeier, D.; Thiele, M.; Schmucker, J.; Geiger, G.; Tovar, G.E.M.; Bernhagen, J. | Zeitschriftenaufsatz |
| 2003 | The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis
Nguyen, M.T.; Lue, H.; Kleemann, R.; Thiele, M.; Tolle, G.; Finkelmeier, D.; Wagner, E.; Braun, A.; Bernhagen, J. | Zeitschriftenaufsatz |
| 2000 | Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
Kleemann, R.; Hausser, A.; Geiger, G.; Mischke, R.; Burger-Kentischer, A.; Flieger, O.; Johannes, F.-J.; Roger, T.; Calandra, T.; Kapurniotu, A.; Grell, M.; Finkelmeier, D.; Brunner, H.; Bernhagen, J. | Zeitschriftenaufsatz |